Literature DB >> 31750222

A Clinical Study on Audiological Evaluation in Patients with Active Squamous Variety of Chronic Otitis Media Following Canal Wall Down Mastoidectomy with Ossicular Reconstruction.

Anindita Sengupta1, Soumik Basu1, Mridul Janweja1, Arunabha Sengupta1.   

Abstract

To evaluate hearing results following canal wall down mastoidectomy with ossicular reconstruction for Chronic Suppurative Otitis Media of Active Squamosal variety & evaluate various factors related to surgery impacting hearing results. This prospective study involves 40 patients of active squamosal variety of chronic otitis media who attended ENT OPD and underwent canal wall down mastoidectomy with ossiculoplasty during the period from November 2014 to October 2015. All the patients were subjected to pre and 3 months post-op hearing assessment. Based on the hearing outcome, we expressed our study results into two groups, those with statistically significant improvement after surgery (T1) and those whose hearing got worsened or remained the same (T2). The mean post operative hearing gain of patients was 5.25 ± 7.30 dB, The median post-op hearing gain was 5.20 dB. Mean pre-operative hearing loss (AB gap) was 41.28 dB. Mean post-operative hearing loss (AB gap) was 36.24 with the average 3 months post-operative hearing gain was 5.2 dB, which reflects a definite improvement. There is a statistically significant hearing improvement (with an average of 5.2 dB AB gap closure) following Canal Wall Down Mastoidectomy with ossiculoplasty as established in the study. © Association of Otolaryngologists of India 2019.

Entities:  

Keywords:  Audiology; Mastoidectomy; Ossiculoplasty; Otitis media

Year:  2019        PMID: 31750222      PMCID: PMC6841767          DOI: 10.1007/s12070-019-01680-4

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  11 in total

1.  Ossiculoplasty using hydroxyapatite prostheses: long-term results.

Authors:  T Shinohara; K Gyo; T Saiki; N Yanagihara
Journal:  Clin Otolaryngol Allied Sci       Date:  2000-08

2.  Revision surgery for canal wall down mastoidectomy: intra-operative findings and results.

Authors:  Sujuan Li; Juan Meng; Fan Zhang; Xiaohua Li; Zhaobing Qin
Journal:  Acta Otolaryngol       Date:  2015-09-25       Impact factor: 1.494

3.  Role of ossiculoplasty in canal wall down tympanoplasty for middle-ear cholesteatoma: hearing results.

Authors:  E De Corso; M R Marchese; B Sergi; M Rigante; G Paludetti
Journal:  J Laryngol Otol       Date:  2006-11-24       Impact factor: 1.469

Review 4.  Retrograde mastoidectomy.

Authors:  John L Dornhoffer
Journal:  Otolaryngol Clin North Am       Date:  2006-12       Impact factor: 3.346

5.  Results of primary ossiculoplasty and prognostic factors in canal wall-down tympanoplasty.

Authors:  Taşkin Umit; Yigit Ozgur; Guntekin Bilgehan; Sunter A Volkan; Sisman A Sezim
Journal:  J Craniofac Surg       Date:  2010-03       Impact factor: 1.046

6.  Mastoidectomy in noncholesteatomatous chronic suppurative otitis media: is it necessary?

Authors:  F R Balyan; S Celikkanat; A Aslan; A Taibah; A Russo; M Sanna
Journal:  Otolaryngol Head Neck Surg       Date:  1997-12       Impact factor: 3.497

7.  Ossiculoplasty in canal wall down mastoidectomy.

Authors:  L P Berenholz; F M Rizer; J M Burkey; A G Schuring; W H Lippy
Journal:  Otolaryngol Head Neck Surg       Date:  2000-07       Impact factor: 3.497

8.  The impact of fixated glass ionomer cement and springy cortical bone incudostapedial joint reconstruction on hearing results.

Authors:  Hatice Celik; Sevim Aslan Felek; Ahmet Islam; Munir Demirci; Erdal Samim; Derya Oztuna
Journal:  Acta Otolaryngol       Date:  2009-12       Impact factor: 1.494

9.  Results of revision mastoidectomy.

Authors:  Sami Berçin; Ahmet Kutluhan; Kazim Bozdemir; Gökhan Yalçiner; Neslihan Sari; Ozgür Karamese
Journal:  Acta Otolaryngol       Date:  2009-02       Impact factor: 1.494

10.  Myringoplasty--effects on hearing and contributing factors.

Authors:  J H Black; P J Wormald
Journal:  S Afr Med J       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.